Influenza virus-induced lung inflammation was modulated by cigarette smoke exposure in mice

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Han, Yan ^a   Ling, Man To ^a   Mao, Huawei ^a   Zheng, Jian ^a   Liu, Ming ^b   Lam, Kwok Tai ^a   Liu, Yuan ^a   Tu, Wenwei ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; CHEMOKINE; NICOTINE;

2009 H1N1 INFLUENZA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN INFLUENZA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; EXPOSURE; FEMALE; IMMUNE DEFICIENCY; INFECTION RISK; INFLUENZA VIRUS A H9N2; LUNG INJURY; LYMPHOCYTIC INFILTRATION; MACROPHAGE MIGRATION; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; RISK ASSESSMENT; SMOKING; VIRUS VIRULENCE; WEIGHT REDUCTION; WILD TYPE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; CHEMOKINES; COTININE; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA, HUMAN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NICOTINE; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA; SEVERITY OF ILLNESS INDEX; SMOKING; TIME FACTORS; UP-REGULATION; WEIGHT GAIN;

EID: 84903378472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086166     Document Type: Article

References (59)

1. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
2. Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF (2012) Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol 2: 276-286.
3. WHO (2009) Acute Respiratory Infections (Update September 2009).
4. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, et al. (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 12: 687-695.
5. Butt KM, Smith GJ, Chen H, Zhang LJ, Leung YH, et al. (2005) Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol 43: 5760-5767. (Pubitemid 41612358)
6. WHO (1999) 1999- Influenza A(H9N2) in Hong Kong Special Administrative Region (SAR) and China - Update.
7. WHO (2003) Influenza A(H9N2) in Hong Kong Special Administrative Region of China (SAR).
8. Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, et al. (2013) PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 123: 206-214.
9. Arcavi L, Benowitz NL (2004) Cigarette smoking and infection. Arch Intern Med 164: 2206-2216. (Pubitemid 39452980)
10. Goncalves RB, Coletta RD, Silverio KG, Benevides L, Casati MZ, et al. (2011) Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm Res 60: 409-424.
11. Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372-377.
12. Gardi C, Valacchi G (2012) Cigarette smoke and ozone effect on murine inflammatory responses. Ann N Y Acad Sci 1259: 104-111.
13. Jackson KJ, Walters CL, Miles MF, Martin BR, Damaj MI (2009) Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice. Neuropharmacology 57: 347-355.
14. Andersson U, Tracey KJ (2012) Reflex principles of immunological homeostasis. Annu Rev Immunol 30: 313-335.
15. Rogot E, Murray JL (1980) Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Rep 95: 213-222. (Pubitemid 10061912)
16. Kark JD, Lebiush M (1981) Smoking and epidemic influenza-like illness in female military recruits: a brief survey. Am J Public Health 71: 530-532. (Pubitemid 11156476)
17. Kark JD, Lebiush M, Rannon L (1982) Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. N Engl J Med 307: 1042-1046. (Pubitemid 12027060)
18. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, Sanasuttipun W, Shinde V, et al. (2009) Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 4: e6051.
19. Wilson KM, Pier JC, Wesgate SC, Cohen JM, Blumkin AK (2013) Secondhand tobacco smoke exposure and severity of influenza in hospitalized children. J Pediatr 162: 16-21.
20. Ling MT, Tu W, Han Y, Mao H, Chong WP, et al. (2012) Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection. J Infect Dis 205: 44-53.
21. Doherty PC, Turner SJ, Webby RG, Thomas PG (2006) Influenza and the challenge for immunology. Nat Immunol 7: 449-455.
22. Tu W, Mao H, Zheng J, Liu Y, Chiu SS, et al. (2010) Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 84: 6527-6535.
23. Chan KH, Ho SP, Yeung SC, So WH, Cho CH, et al. (2009) Chinese green tea ameliorates lung injury in cigarette smoke-exposed rats. Respir Med 103: 1746-1754.
24. Wong HP, Li ZJ, Shin VY, Tai EK, Wu WK, et al. (2009) Effects of cigarette smoking and restraint stress on human colon tumor growth in mice. Digestion 80: 209-214.
25. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, et al. (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190: 269-319. (Pubitemid 46156883)
26. Tu W, Zheng J, Liu Y, Sia SF, Liu M, et al. (2011) The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice. J Exp Med 208: 1511-1522.
27. Goodman AG, Fornek JL, Medigeshi GR, Perrone LA, Peng X, et al. (2009) P58(IPK): a novel ''CIHD'' member of the host innate defense response against pathogenic virus infection. PLoS Pathog 5: e1000438.
28. Zheng J, Liu Y, Qin G, Chan PL, Mao H, et al. (2009) Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J Immunol 183: 3742-3750.
29. Qin G, Liu Y, Zheng J, Ng IH, Xiang Z, et al. (2011) Type 1 responses of human Vgamma9Vdelta2 T cells to influenza A viruses. J Virol 85: 10109-10116.
30. Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL (1998) Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res 243: 359-366. (Pubitemid 28488846)
31. Dickson PE, Rogers TD, Lester DB, Miller MM, Matta SG, et al. (2011) Genotype-dependent effects of adolescent nicotine exposure on dopamine functional dynamics in the nucleus accumbens shell in male and female mice: a potential mechanism underlying the gateway effect of nicotine. Psychopharmacology (Berl) 215: 631-642.
32. Hukkanen J, Jacob P 3rd, Benowitz NL (2005) Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57: 79-115. (Pubitemid 40283970)
33. Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE (2007) Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol 179: 6097-6106.
34. Gaschler GJ, Zavitz CC, Bauer CM, Skrtic M, Lindahl M, et al. (2008) Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. Am J Respir Cell Mol Biol 38: 218-226. (Pubitemid 351162844)
35. Kang YM, Song BM, Lee JS, Kim HS, Seo SH (2011) Pandemic H1N1 influenza virus causes a stronger inflammatory response than seasonal H1N1 influenza virus in ferrets. Arch Virol 156: 759-767.
36. Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, et al. (2006) Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis 194: 61-70.
37. Gualano RC, Hansen MJ, Vlahos R, Jones JE, Park-Jones RA, et al. (2008) Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice. Respir Res 9: 53.
38. Robbins CS, Bauer CM, Vujicic N, Gaschler GJ, Lichty BD, et al. (2006) Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am J Respir Crit Care Med 174: 1342-1351. (Pubitemid 44913036)
39. Schmitz N, Kurrer M, Bachmann MF, Kopf M (2005) Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 79: 6441-6448. (Pubitemid 40617247)
40. Paquette SG, Banner D, Zhao Z, Fang Y, Huang SS, et al. (2012) Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One 7: e38214.
41. Darwish I, Mubareka S, Liles WC (2011) Immunomodulatory therapy for severe influenza. Expert Rev Anti Infect Ther 9: 807-822.
42. Liu Y, Chen H, Sun Y, Chen F (2012) Antiviral role of Toll-like receptors and cytokines against the new 2009 H1N1 virus infection. Mol Biol Rep 39: 1163-1172.
43. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, et al. (2009) IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 182: 7353-7363.
44. Jones SA (2005) Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175: 3463-3468.
45. Longhi MP, Wright K, Lauder SN, Nowell MA, Jones GW, et al. (2008) Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells. PLoS Pathog 4: e1000006.
46. Brusselle GG, Joos GF, Bracke KR (2011) New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378: 1015-1026.
47. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, et al. (2008) Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 205: 3065-3077.
48. Damjanovic D, Small CL, Jeyananthan M, McCormick S, Xing Z (2012) Immunopathology in influenza virus infection: uncoupling the friend from foe. Clin Immunol 144: 57-69.
49. Moskophidis D, Kioussis D (1998) Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med 188: 223-232. (Pubitemid 28357751)
50. Bauer CM, Zavitz CC, Botelho FM, Lambert KN, Brown EG, et al. (2010) Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS One 5: e13251.
51. Jaspers I, Horvath KM, Zhang W, Brighton LE, Carson JL, et al. (2010) Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza. Am J Respir Cell Mol Biol 43: 368-375.
52. Noah TL, Zhou H, Monaco J, Horvath K, Herbst M, et al. (2011) Tobacco smoke exposure and altered nasal responses to live attenuated influenza virus. Environ Health Perspect 119: 78-83.
53. Lunney PC, Leong RW (2012) Review article: Ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 36: 997-1008.
54. Guslandi M (1999) Nicotine treatment for ulcerative colitis. Br J Clin Pharmacol 48: 481-484.
55. Misery L (2004) Nicotine effects on skin: are they positive or negative? Exp Dermatol 13: 665-670.
56. Wittebole X, Hahm S, Coyle SM, Kumar A, Calvano SE, et al. (2007) Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol 147: 28-34. (Pubitemid 44915552)
57. Razani-Boroujerdi S, Singh SP, Knall C, Hahn FF, Pena-Philippides JC, et al. (2004) Chronic nicotine inhibits inflammation and promotes influenza infection. Cell Immunol 230: 1-9. (Pubitemid 39482356)
58. Sopori ML, Kozak W, Savage SM, Geng Y, Soszynski D, et al. (1998) Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 23: 189-204. (Pubitemid 28248471)
59. Huttunen R, Heikkinen T, Syrjanen J (2011) Smoking and the outcome of infection. J Intern Med 269: 258-269.